IMC 003 - Immuno Cure
Alternative Names: IMC-003 - Immuno CureLatest Information Update: 24 May 2024
At a glance
- Originator Immuno Cure
- Class Antineoplastics; Cancer vaccines; DNA vaccines; Immunotherapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Mesothelioma
Most Recent Events
- 26 Apr 2024 Investigation in Mesothelioma in China (IM) (Immuno Cure pipeline, April 2024)
- 26 Apr 2024 Pharmacodynamics data from a preclinical trial in Mesothelioma released by Immuno Cure (Immuno Cure pipeline, April 2024)